Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

Relief in sight for sinus sufferers

- Featured Image

People who suffer from painful and recurring sinus infections could soon have a new targeted spray treatment.

Researchers from the Woolcock Institute of Medical Research have been awarded a grant to develop a much-needed new treatment for chronic sinus infection.

Currently, 16 per cent of Australians suffer from severe discomfort and pain as a result of recurring sinus infections, triggered when mucus made in the sinuses fails to drain properly.

Lead researcher Associate Professor Paul Young said it was amazing that chronic sinus infection affected such a large percentage of the population and yet there was currently no nasal spray or device capable of specifically targeting the condition.

Suffers are prescribed antibiotics, mucus dissolvents or steroids, approaches that Woolcock researcher Associate Professor Greg King said gave virtually no access to the sinuses, and had limited therapeutic efficacy.

“Our goal is to develop a carefully targeted treatment that carries a formulation capable of simultaneously removing mucus, dispersing biofilms and killing bacteria hiding deep in the sinuses,” Associate Professor Greg King said.

Kirsty Waterford